Ironwood Pharmaceuticals, Inc. share price logo

Ironwood Pharmaceuticals, Inc. Share Price

NASDAQ: IRWD

Small Cap

$3.28

+0.24

(+7.89%)

as on

Ironwood Pharmaceuticals, Inc. Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.18
    $3.40
    downward going graph

    3.05%

    Downside

    3.66%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.53
    $5.78
    downward going graph

    83.93%

    Downside

    76.22%

    Upside

    downward going graph

Ironwood Pharmaceuticals, Inc. share price movements today

Previous Close
$3.04
Open
$3.21
Volume
2.2M
Day's Low - High
$3.18 - $3.40
52 Week Low - High
$0.53 - $5.78

Ironwood Pharmaceuticals, Inc. Historical Returns

1 Month Return
-18.93 %
3 Month Return
-5.3 %
1 Year Return
+ 115.6 %
3 Year Return
-71.08 %
5 Year Return
-71.83 %

Ironwood Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Ironwood Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$495.7M

EPS (TTM)

1.35

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

10.47%

PE Ratio (TTM)

20.27

Industry PE ratio

-4.738881355932204

PEG Ratio

-0.26

EBITDA

120.6M

Revenue (TTM)

296.2M

Profit Margin

8.11%

Return On Equity TTM

-574.72%

Ironwood Pharmaceuticals, Inc. Stock Valuation

Track how Ironwood Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Ironwood Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-22.60x)

March 31, 2025

Industry (-4.74x)

March 23, 2026

Today (20.27x)

March 23, 2026

Highest (129.55x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 20.27x

Ironwood Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ironwood Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$495.7M-71.83%20.278.11%
BUY$23.0BNA18.8141.94%
HOLD$15.2B-6.85%-21.95-24.58%
BUY$44.8BNA20.5515.11%
BUY$51.0B-25.87%19.2528.24%

Stock Returns calculator for Ironwood Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Ironwood Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ironwood Pharmaceuticals, Inc. investment value today

Current value as on today

₹2,42,543

Returns

₹1,42,543

(+142.54%)

Returns from Ironwood Pharmaceuticals, Inc. Stock

₹1,32,624 (+132.62%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Ironwood Pharmaceuticals, Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Ironwood Pharmaceuticals, Inc.. Average target price of $6.1

Ironwood Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Ironwood Pharmaceuticals, Inc..

What analysts predicted

46.23%UPSIDE

Target Price

$6.1

Current Price

$3.28

Analyzed by

12 Analysts

Target

$6.10

Ironwood Pharmaceuticals, Inc. target price $6.1, a slight upside of 46.23% compared to current price of $3.28. According to 12 analysts rating.

Ironwood Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest

Search interest for Ironwood Pharmaceuticals, Inc. Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Ironwood Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
113
117
74
94
91
90
41
85
122
47
Gross Profit
113
117
49
94
61
90
13
85
122
47
Operating Income
48
37
11
24
25
31
-29
45
75
6
EBITDA
42
40
11
26
27
33
-10
46
76
8
Interest Expense
9
8
7
7
9
8
8
8
8
7
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
31
30
4
18
17
23
-36
37
68
0
Income Tax Expense
17
32
9
19
13
21
1
14
27
2
Net Income
15
-1
-4
0
3
2
-37
23
40
-2
Net Profit Margin
13.47%
-0.92%
-5.56%
-0.91%
3.98%
2.49%
-90.87%
27.69%
32.84%
-4.77%

Ironwood Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
273
298
346
428
389
413
410
442
351
296
Gross Profit
272
278
313
293
386
343
409
436
343
294
Operating Income
-51
-77
-238
120
142
232
250
-945
93
118
EBITDA
-31
-33
-144
128
141
233
261
197
97
104
Interest Expense
39
36
37
36
29
31
7
21
33
32
Depreciation
-
14
14
5
3
1
1
1
2
1
Income Before Tax
-81
-116
-282
58
108
200
252
-948
65
70
Income Tax Expense
37
34
-5
74
2
-327
77
83
64
46
Net Income
-81
-116
-282
21
106
528
175
-1,002
0
24
Net Profit Margin
-29.83%
-39.20%
-81.46%
5.02%
27.26%
127.72%
42.64%
-226.37%
0.25%
8.11%

Ironwood Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
-4
0
3
3
-37
23
40
61
Operating Cash Flow
35
44
33
9
15
19
-15
47
74
Investing Cash Flow
-4
0
0
0
0
0
0
0
0
Financing Cash Flow
-50
-15
-49
-27
-14
0
0
-
0
Change in Cash
-19
29
-16
-17
0
19
-15
47
75

Ironwood Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-116
-282
21
106
528
175
-1,002
0
24
Operating Cash Flow
-99
-70
10
168
261
273
183
103
127
Investing Cash Flow
151
88
-11
-1
0
0
-1,026
0
0
Financing Cash Flow
19
30
-1
18
-4
-237
277
-106
0
Change in Cash
71
48
-1
185
257
36
-565
-3
126

Global Institutional Holdings in Ironwood Pharmaceuticals, Inc.

Funds
Holdings
Charles Schwab Investment Management Inc
3.05%
AQR Capital Management LLC
2.9%
Marshall Wace Asset Management Ltd
1.93%
Geode Capital Management, LLC
2.22%
Two Sigma Advisers, LLC
1.93%

Ironwood Pharmaceuticals, Inc. News & Key Events

  • img

    Today's Timeline - 26 November

    Wed, 05:48 PM

    -

    Ironwood shares rise 1.3% after Medicare sets LINZESS price at $136 for 30-day supply, effective January 1, 2027.

Insights on Ironwood Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IRWD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, IRWD stock has moved up by 118.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 142.7% return, outperforming this stock by 213.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 122.06M → 47.70M (in $), with an average decrease of 60.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 40.08M → -2.27M (in $), with an average decrease of 105.7% per quarter

About Ironwood Pharmaceuticals, Inc.

ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b
OrganisationIronwood Pharmaceuticals, Inc.
Headquarters100 Summer Street, Boston, MA, United States, 02110
IndustryHealth Technology
CEOMr. Thomas A. McCourt
E-voting on sharesClick here to vote

Key Management of Ironwood Pharmaceuticals, Inc.

Name

Title

Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.

VP & Global Head of Technical Operations

Ms. Tammi Gaskins

Senior Vice President & Chief Commercial Officer.

Mr. Jeff Ruberti

Chief Strategy Officer

Mr. Thomas A. McCourt

CEO & Director

Mr. John Minardo

Senior VP, Chief Legal Officer & Secretary

Dr. Michael Shetzline M.D., Ph.D.

Chief Medical Officer, Senior VP and Head of Research & Drug Development

Mr. Gregory Martini

Senior VP, CFO & Investor Relations

Mr. Ronald Silver

Senior VP, Corporate Controller & Principal Accounting Officer

FAQs

What is Ironwood Pharmaceuticals, Inc. share price today?

Ironwood Pharmaceuticals, Inc. share price today is $3.28 as on at the close of the market. Ironwood Pharmaceuticals, Inc. share today touched a day high of $3.4 and a low of $3.18.

What is the 52 week high and 52 week low for Ironwood Pharmaceuticals, Inc. share?

Ironwood Pharmaceuticals, Inc. share touched a 52 week high of $5.78 on and a 52 week low of $0.53 on . Ironwood Pharmaceuticals, Inc. stock price today i.e. is closed at $3.28,which is 43.25% down from its 52 week high and 522.27% up from its 52 week low.

What is Ironwood Pharmaceuticals, Inc.'s market capitalisation today?

Ironwood Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Ironwood Pharmaceuticals, Inc. Stock (IRWD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ironwood Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ironwood Pharmaceuticals, Inc. Shares that will get you 0.4573 shares as per Ironwood Pharmaceuticals, Inc. share price of $3.28 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ironwood Pharmaceuticals, Inc. Stock (IRWD) from India?

Indian investors can start investing in Ironwood Pharmaceuticals, Inc. (IRWD) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Ironwood Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Ironwood Pharmaceuticals, Inc. share’s latest price of $3.28 as on March 24, 2026 at 1:29 am IST, you will get 3.0488 shares of Ironwood Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Ironwood Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Ironwood Pharmaceuticals, Inc. stock has given -71.83% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?